Contact HIV/AIDS
Info on HIV/AIDS:
206-205-7837
TTY: 206-296-4843
Toll-free: 800-678-1595
Administration:
206-296-4649
HIV/STD Testing
HIV/STD Hotline:
206-205-7837 or
Toll-free: 800-678-1595
11:00 am to 4:00 pm
Monday - Friday for
testing information, resources and referrals
|
|
HIV/AIDS Program
Bibliographies for March 2000
| 1. |
Fishbein M and Pequegnat W. Evaluation AIDS Prevention Interventions Using Behavioral and Biological Outcome Measures. Sexually Transmitted Diseases, February 2000; 27(2):101-110.
|
| 2. |
Richens J, Imrie J and Copas A. Condoms and Seat Belts: the Parallels and the Lessons. The Lancet, January 29, 2000; 355:400-403.
|
| 3. |
O'Farrell N and Egger M. Circumcision in Men and the Prevention of HIV Infection: a 'Meta-Analysis' Revisited. International Journal of STD & AIDS; 11(3):1-2.
|
| 4. |
Zierler S, Cunningham W, et al. Violence Victimization After HIV Infection in a US Probability Sample of Adult Patients in Primary Care. American Journal of Public Health; February 2000; 90(2):208-215
|
| 5. |
Cheonis M. Status Report on HIV Vaccine Development. Beta, Year-end 1999:40-48
|
| 6. |
Bensley LS, Van Eenwyk J and Simmons KW. Self-Reported Childhood Sexual and Physical Abuse and adult HIV-Risk Behaviors and Heavy Drinking. American Journal of Preventive Medicine; February 2000:151-158
|
| 7. |
Des Jarlais DC. Prospects for a Public Health Perspective on Psychoactive Drug Use. American Journal of Public Health, March. 2000; 90(3):335-337.
|
| 8. |
Ferrini R. American College of Preventive Medicine Public Policy on Needle-Exchange Programs to Reduce Drug-Associated Morbidity and Mortality. American Journal of Preventive Medicine 2000; 18(2):173-175.
|
| 9. |
The Role of Pharmacies in Preventing HIV Among Injection Drug Users. AIDS Information Exchange- United States Conference of Mayors, December 1999: 1-11.
|
| 10. |
Des Jarlais DC, Marmor M, et al. HIV Incidence Among Injection Drug Users in New York City, 1992-1997: Evidence for a Declining Epidemic. American Journal of Public Health, March 2000; 90(3)352-359.
|
| 11. |
Song JT, Tesselaar H, et al. HIV Risk Behaviors Among Homeless Injection Drug Users of Different Ethnicities. AIDS and Behavior, 1999; 3(3)187-194.
|
| 12. |
Rounsaville BJ and Kosten TR. Treatment for Opioid Dependence: Quality and Access. Journal of the American Medical Association, March 8, 2000;283(10):1337-1339.
|
| 13. |
Sees KL, Delucci KL et al. Methadone Maintenance vs 180-Day Psychosocially Enriched Detoxification for Treatment of Opioid Dependence: A Randomized Controlled Trial. Journal of the American Medical Association, March 8, 2000;283(10):1303-1310
|
| 14. |
Weinrich M and Stuart M. Provision of Methadone Treatment in Primary Medical Practices: Review of the Scottish Experience and Implications for US Policy. Journal of the American Medical Association, March 8, 2000;283(10):1343-1348.
|
| 15. |
Aristeiguieta CA. Screening Patients for Alcohol, Tobacco and Other Drug Misuse: the Role of Brief Interventions. West Journal of Medicine, 2000;172:53-57.
|
Men Who Have Sex With Men
|
| 16. |
Imrie J, Fenton KA and Billington A. HIV Prevention and Homosexual Men: Should We Be Optimistic About the New Millennium? Sexually Transmitted Diseases, 1999; 75:369-376.
|
| 17. |
HIV/AIDS Among Racial/Ethnic Minority Men Who Have Sex With Men-- United States, 1989-1998.Morbidity & Mortality Weekly Report; 49(1):4-11.
|
| 18. |
Dean L, Meyer I, et al. Lesbian, Gay, Bisexual and Transgender Health: Findings and Concerns. January 2000 Conference Edition, Gay and Lesbian Medical Association.
|
| 19. |
Lauby Jl, Smith PJ, et al. A
Community-Level HIV Prevention Intervention for Inner-City Women:
Results of the Women and Infants Demonstration Projects. American
Journal of Public Health, February 2000; 90(2)216-222. |
| 20. |
Arts L, Macluso M, et al. Effectiveness
of an Intervention Promoting the Female Condom to Patients at Sexually
Transmitted Disease Clinics. American Journal of Public Health, February 2000; 90(2)237-244. |
| 21. |
Witte SS, Takeshi W, et al. Predictors
of Female Condom Use Among Women Exchanging Street Sex in New York
City. Sexually Transmitted Diseases, February 2000: 93-100. |
| 22. |
Van Damme L, Chandeying V, et
al. Safety of Multiple Daily Applications of COL-1492, a Nonoxynol-9
Vaginal Gel, Among Female Sex Workers. AIDS 2000; 14(1)85-88. |
| 23. |
Coggins, C. Avoiding HIV Transmission:
Women Need More Options. Sexually Transmitted Diseases,
1999; 75:374-375. |
| 24. |
Potts, M. Thinking About Vaginal
Microbicide Testing. American Journal of Public Health, February
2000; 90(2)188-190. |
| 25. |
Hanna L. Conferences Raise
New Questions About HAART Use by Women. Beta, Year-end
1999:30-39. |
| 26. |
Ellerbrock TV, Chiasson, MA, et
al. Incidence of Cervical Squamous Intraepithelial Lesions in HIV-Infected
Women. Journal of the American Medical Association, February
23, 2000; 283(8)1031-1037. |
| 27. |
Panchaud C, Singh S, et al. Sexually
Transmitted Diseases Among Adolescents in Developed Countries. Family
Planning Perspectives, 2000; 32(1):24-32&45. |
| 28. |
Szekeres G. HIV/AIDS in Adolescence. Beta, Year-End 1999: 49-53. |
| 29. |
Ward, K and Waters J. The Impact
of Targeted Prevention Programs for Adolescents at high risk for HIV
Transmission. Journal of HIV/AIDS Prevention & Education
for Adolescents and Children, 3 (1/2 1999):51-77. |
| 30. |
scicki A, Ellenberg JH, et al. Prevalence and Risks for Cervical Human Papillomavirus Infection
and Squamous Intraepithelial Lesions in Adolescent Girls: Impact of
Infection with Human Immunodeficiency Virus. Arch Pediatric
and Adolescent Medicine, February 2000; (154):127-134. |
| 31. |
Srugo I, Gershtein R, et al. Acute
Primary Chlamydia Trachomatis Infection in Male Adolescents After
Their First Sexual Contact. Arch Pediatric and Adolescent Medicine, February 2000; (154):169-172. |
| 32. |
Alstead M, Campsmith M, et al. Developing, Implementing and Evaluating a Condom Promotion Progaram
Targeting Sexually Active Adolescents. AIDS Education and Prevention, 1999; 11(6):497-512. |
| 33. |
Bush-Parker, T. Perinatal HIV:
Children with HIV Grow Up. Focus, January 2000; 15(2):1-6. |
| 34. |
Nduati R, John G, et al. Effect
of Breastfeeding and Formula Feeding on Transmission of HIV-1: A Randomized
Clinical Trial. Journal of the American Medical Association, March 1, 2000; 283(9):1167-1174. |
| 35. |
WHO Collaborative Study Team on
the Role of Breastfeeding. Effect of Breastfeeding On Infant and
Child Mortality Due to Infectious Diseases in Less Developed Countries:
A Pooled Analysis. The Lancet, February 5, 2000; 355:451-455. |
| 36. |
DeCock KM, Fowler MG, et al. Prevention
of Mother-to-Child HIV Transmission in Resource-Poor Countries: Translating
Research into Policy and Practice. Journal of the American
Medical Association, March 1, 2000; 283(9):1175-1182. |
Sexually Transmitted Diseases
|
| 37. |
Cohen DA and Scribner R. An
STD/HIV Prevention Intervention Framework. AIDS Patient Care
and STDs, 2000; 14(1):37-45. |
| 38. |
Celantano DD, Bond KC, at al. Preventive Intervention to Reduce Sexually Transmitted Disease
Infections: A Field Trial in the Royal Thai Army. Arch Internal
Medicine, February 28, 2000; 160:535-540. |
| 39. |
Tao G, IrwinKL and Kassler WJ. Missed Opportunities to Assess Sexually Transmitted Diseases in
U.S. Adults During Routine Medical Checkups. American Journal
of Preventive Medicine, 2000; 18(2):109-114. |
| 40. |
Corey L and Handsfield HH. Genital
Herpes and Public Health: Addressing a Global Problem. Journal
of the American Medical Association, February 9, 2000; 283(9):791-794. |
| 41. |
Corey L. Herpes Simplex Type
2 Infection in the Developing World: Is It Time To Address This Disease? Sexually Transmitted Diseases, January 2000; 27(1):30-31/ |
| 42. |
Guoyu, T, Kassler WJ and Rein
DB. Medical Care Expenditures for Genital Herpes. Sexually
Transmitted Diseases, January 2000; 27(1):32-38. |
| 43. |
O'Farrell N. Increasing Prevalence
of Genital Herpes in Developing Countries: Implications for Heterosexual
HIV Transmission and STI Control Programmes. Sexually Transmitted
Infections, 1999;75:377-384. |
| 44. |
Lewis DA. Chancroid: From Clinical
Practice to Basic Science. AIDS Patient Care and STDs, 2000;
14(1):19-36. |
| 45. |
Martin IMC and Ison CA.. Rise
in Gonorrhea in London, UK. The Lancet, February 19, 2000;
355:623. |
| 46. |
Torian LV, Makki HA et al. High
HIV Seroprevalence Associated with Gonorrhea: New York City Department
of Health, Sexually Transmitted Disease Clinics, 1990-1997. AIDS 2000; 14:189-195. |
| 47. |
Cohen D, Spear S, et al. "Broken
Windows" and the Risk of Gonorrhea. American Journal of Public
Health, February 2000; 90(2):230-236. |
| 48. |
Bradner CH, Ku L and Lindberg
LD. Older but not wiser: How Men Get Information About AIDS and
Sexually Transmitted Diseases After High School. Family Planning
Perspectives, January/February 2000; 32(1):33-38. |
| 49. |
Zimet GD, Mays RM and Fortenberry
JD. Vaccines Against Sexually Transmitted Infections: Promise and
Problems of the Magic Bullets for Prevention and Control. Sexually
Transmitted Diseases, January 2000; 27(1):49-52. |
HIV Testing and Partner Notification
|
| 50. |
White E, Katz MH and McFarland
W. Whom Does Partner Notification for HIV Infection Serve in San
Francisco? A Review of Counseling and Testing Data From 1995-1997. AIDS and Behavior,1999; 3(3):205-211. |
| 51. |
Joo E, Carmack A et al. Implementation
of Guidelines for Counseling and Voluntary HIV Testing of Pregnant
Women. American Journal of Public Health, February 2000;
90(2):273-276. |
| 52. |
CDC Guidelines
for National Human Immunodeficiency Virus Case Surveillance, Including
Monitoring for Human Immunodeficiency Virus Infection and Acquired
Immunodeficiency Syndrome. Supplement to Morbidity and Mortality
Weekly Report, December 10, 1999; 48(RR-13). |
| 53. |
Liang TJ, Rehermann B, Seeff LB
and Hoofnagle JH. Pathogenesis, Natural History, Treatment and
Prevention of Hepatitis C. Annals of Internal Medicine,
15 February 2000; 132(4):296-305. |
| 54. |
Highleyman L. Natural History
and Treatment of Hepatitis C. Beta,Year-End 1999:16-29. |
| 55. |
Seeff LB, Miller RN et al. 45-Year
Follow-up of Hepatitis C Virus Infection in Healthy Young Adults. Annals of Internal Medicine, 18 January 2000; 132(2):105-111. |
| 56. |
Kane M, Bantavala J at al. Are
Booster Immunizations Needed for Lifelong Hepatitis B Immunity? The
Lancet, February 12, 2000; 355:561-565. |
Anti-Retroviral Treatment
|
| 57. |
Gallant JE. Strategies for
Long-term Success in the Treatment of HIV Infection. Journal
of the American Medical Association, March 8, 2000; 283(10):1329-1334. |
| 58. |
Henry K. The Case for More
Cautious, Patient-Focused Antiretroviral Therapy. Annals of
Internal Medicine, 15 February 2000; 132(4):306-311. |
| 59. |
Cohen OJ. Antiretroviral Therapy:
Time to think Strategically. Annals of Internal Medicine, 15
February 2000; 132(4):320-322. |
| 60. |
Piscitelli SC, Burstein AH et
al. Indinavir Concentrations and St. John's Wort. The Lancet,
February 12, 2000; 355:547-548. |
| 61. |
Lori F, Foli A et al. Structured
Treatment Interruptions to Control HIV-1 Infection. The Lancet, January 22, 2000; 354:287-288. |
| 62. |
Vernazza PL, Troiani L et al. Potent Antiretroviral Treatment of HIV-Infection Results in Suppression
of the Seminal Shedding of HIV. AIDS 2000; 14(12):117-121. |
| 63. |
Salomon H, Wainberg MA et al. Prevalence of HIV-1 Resistant to Antiretroviral Drugs in 81 Individuals
Newly Infected by Sexual Contact or Injecting Drug Use. AIDS
2000; 14(12):F17-F23. |
| 64. |
Murphy DA, Roberts KJ et al. Barriers
to Antiretroviral Adherance Among HIV-Infected Adults. AIDS
Patient Care and STDs, 2000; 14(1):47-58. |
| 65. |
Hubert J-B, Burgard M et al. Natural
History of Serum HIV-1 RNA Levels in 330 Patients With a Known Date
of Infection. AIDS 2000; 14:123-131. |
| 66. |
Weidle PJ, Ganea CE et al. Presence
of Human Immunodeficiency Virus (HIV) Type 1, Group M, Non-B Subtypes,
Bronx, New York: A Sentinel Site for Monitoring HIV Genetic Diversity
in the United States. The Journal Of Infectious Diseases, 200;
181:470-475. |
| 67. |
Sullivan PS, Do AN et al. Human
Immunodeficiency Virus (HIV) Subtype Surveillance of African-Born
Persons at Risk for Group O and Group N HIV Infections in the United
States. The Journal Of Infectious Diseases, 200; 181:463-469. |
| 68. |
Reiter GS. Comprehensive Clinical
Care: Managing HIV as a Chronic Illness. AIDS Clinical Care, February 2000; 12(2):13-20. |
| 69. |
Whitcup SM. Cytomegalovirus
Retinitis in the Era of Highly Active Antiretroviral Therapy. Journal
of the American Medical Association, February 2000; 283(5):653-657. |
| 70. |
Nuorti JP, Butler JC et al. Epidemiologic
Relation Between HIV and Invasive Pneumococcal Disease in San Francisco
County, California. Annals of Internal Medicine, February
2000; 132:182-190. |
| 71. |
Yangco BG, Von Bargen JC et al. Discontinuation of Chemoprophylaxis Against Pneumocystitis carinii
Pneumonia in Patients with HIV Infection. Annals of Internal
Medicine, February 2000; 132:201-205. |
| 72. |
Espinal MA; Peréz NE et
al. Infectiousness of Mycobacterium tuberculosis in HIV-1-Infected
Patients With Tuberculosis: A Prospective Study. The Lancet, January 22, 2000; 355:275-280. |
| 73. |
Diaz PT, King MA at al. Increased Susceptibility to
Pulmonary Emphysema among HIV-Seropositive Smokers. Annals of
Internal Medicine, February 2000; 132:369-372. |
|
|
|
